Results 201 to 210 of about 31,041 (297)
Abstract Aims Serum 1,5‐anhydroglucitol (1,5‐AG) indicates glycemic control over 1–2 weeks and is particularly useful for monitoring postprandial hyperglycemia. However, its predictive value for long‐term outcomes in type 2 diabetes has not been fully established.
Jiaying Ni +9 more
wiley +1 more source
Observable score for bleeding after colorectal endoscopic mucosal resection. [PDF]
Nakazawa H +14 more
europepmc +1 more source
Formulary and economic considerations in the selection of antiplatelet agents
Vicki S. Crane
openalex +1 more source
Primary heart involvement (pHI) is a severe but often overlooked complication of systemic sclerosis (SSc), linked to heart failure, arrhythmias and mortality. In a study of 600 patients from the Italian SPRING‐SIR registry, 25% had ECG or echocardiographic signs of pHI at baseline, associated with older age, diffuse skin disease and intestinal symptoms.
Antonio Tonutti +91 more
wiley +1 more source
Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents. [PDF]
Shibata H +16 more
europepmc +1 more source
Heparin reverses the antiplatelet effect of nitric oxide
Gilbert R. Upchurch +4 more
openalex +1 more source
TGFβ enhances platelet–breast‐cancer‐cell interaction and promotes platelet aggregation
TGFβ stimulation promotes EMT in MCF7 cells, increasing their ability to bind, activate, and aggregate PLT. This effect involves the upregulation of adhesion molecules Integrin‐αv and Galectin‐3. Inhibiting Integrin‐αv or Galectin‐3, through Cilengitide and GB1103, reduces PLT adhesion to MCF7 and PLT aggregation, suggesting a mechanism linking TGFβ ...
Margherita Genitoni +7 more
wiley +1 more source
Antiplatelet Therapy Mitigates Brain Metastasis Risk in Non-Small Cell Lung Cancer: Insights from a Comprehensive Retrospective Study. [PDF]
Martín-Abreu C +4 more
europepmc +1 more source
European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice
ABSTRACT Introduction Glanzmann's thrombasthenia is a rare inherited platelet disorder characterized by a lack of platelet aggregation. Patients tend to be diagnosed in early childhood with treatment strategies involving a multifaceted approach to prevent and manage bleeding episodes.
Mathieu Fiore +6 more
wiley +1 more source

